Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Quetiapine treatment assessed in depression, anxiety and alcoholism

Jan. 11, 2008

Iloperidone effective in double-blind schizophrenia trials

Jan. 11, 2008

Erythropoietin may have antidepressant activity

Jan. 11, 2008

Therapeutic potential of GLS1 inhibition in schizophrenia

Jan. 10, 2008

Ambien CR tablets CIV improve chronic insomnia in GAD patients

Jan. 10, 2008

Alseres completes enrollment in phase I/IIa clinical trial of Cethrin and plans phase IIb trial

Jan. 10, 2008

New ferritin light chain gene mutant mice, useful to study neuroferritinopathy / News in Context

Jan. 9, 2008

Melanin-concentrating hormone, a potential antidepressant target

Jan. 9, 2008

D-Cycloserine does not affect social withdrawal in autistic children

Jan. 9, 2008

Jazz Pharmaceuticals receives orphan drug designation for acute repetitive seizures candidate

Jan. 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...